WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) released the following statement after voting for H.R. 467, HALT Fentanyl Act, on the House floor.
“Inaction on fentanyl is not an option. For Americans 18 to 49 years old, analysis shows this poison is the top cause of death, and fentanyl also tragically takes the lives of kids too soon.
“Many fentanyl-related substances, which can… Read more »
WASHINGTON, D.C. - House Energy and Commerce Committee Subcommittee on Health Chair Brett Guthrie (KY-02) released the following statement praising the passage of the Medicaid VBPs for Patients (MVP) Act through the full Energy and Commerce Committee.
“The Medicaid VBPs for Patients Act would help get life-saving treatments to the most vulnerable patients across the country. With the… Read more »
WASHINGTON, D.C. – House Energy and Commerce Committee Subcommittee on Health Chair Brett Guthrie (KY-02) and Subcommittee on Health Ranking Member Anna G. Eshoo (CA-16) released the following statement applauding the passage of the Medicaid VBPs for Patients (MVP) Act in a Health Subcommittee markup.
“With the passage of the MVP Act at Health Subcommittee markup today, our bill to help… Read more »
WASHINGTON, D.C. — House Energy and Commerce Committee Subcommittee on Health Chair Brett Guthrie (KY-02) and Energy and Commerce Committee Chair Cathy McMorris Rodgers (WA-05) released the following statement as the Biden administration lifts the COVID-19 Public Health Emergency:
“The Biden administration is finally acting on what the President unequivocally stated more than 6 months… Read more »
WASHINGTON, D.C. - Congressman Brett Guthrie (KY-02), who is the Chair of the House Energy and Commerce Committee’s Subcommittee on Health, led the reintroduction of the Medicaid VBPs for Patients (MVP) Act with Subcommittee on Health Ranking Member Anna G. Eshoo (CA-16) and U.S. Representatives John Joyce, M.D. (PA-13), Jake Auchincloss (MA-04), and Mariannette Miller-Meeks (IA-01).
The… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) and Congresswoman Anna Eshoo (CA-16), who serve as the Chair and Ranking Member, respectively, of the House Energy and Commerce Committee Subcommittee on Health, sent a letter to Dr. Peter Marks, the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA), on the backlog of cell and… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), who serves as the Chair of the Energy and Commerce Committee Subcommittee on Health, helped introduce the Ensuring Patient Access to Critical Breakthrough Products Act.
“Breakthrough medical devices can give patients a better quality of life and even save lives. That’s why it’s important to ensure seniors can more quickly access… Read more »
WASHINGTON, D.C. - Congressman Brett Guthrie (KY-02), who serves as Chair of the House Energy and Commerce Committee’s Subcommittee on Health, penned an op-ed in the Washington Examiner on how to empower patients and lower costs through greater price transparency in the health care system.
In the op-ed, Guthrie previews a Subcommittee on Health hearing on March 28, 2023, to examine… Read more »
WASHINGTON, D.C. — House Energy and Commerce Committee Subcommittee on Health Chair Brett Guthrie (KY-02), full committee Chair Cathy McMorris Rodgers (WA-05), Subcommittee on Oversight and Investigations Chair Morgan Griffith (VA-09), and Subcommittee on Energy, Climate, and Grid Security Chair Jeff Duncan (SC-03) released the following statement after the House passed S. 619, a bill to… Read more »
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02) and U.S. Representatives Scott Peters (CA-50), Larry Bucshon, M.D. (IN-08), and Paul D. Tonko (NY-20) introduced the Comprehensive Opioid Recovery Centers Reauthorization Act of 2023 to reauthorize a comprehensive opioid recovery centers program.
“The need for wrap-around, coordinated treatment and recovery support resources for people… Read more »
